Researchers at the Leibniz Institute for Immunotherapy (LIT) have demonstrated that killer T cells of the immune system not only eliminate pathologically altered cells, but also promote the subsequent tissue wound healing process.
Professor Hendrik Poeck receives EU funding of 2 million euros for his research on immunotherapies in leukemia patients. The ERC Consolidator Grant will fund his research for a period of five years.
The former Bavarian State Minister for Science and the Arts, Dr. Thomas Goppel, and Ministerial Councilor Florian Albert visited on September 21, 2023, to get information about the latest developments in immunological research at LIT.
The award-winning work from Dr. Christian Schmidl’s group investigates epigenetic changes in tumor-infiltrating T cells that distinguish functional from dysfunctional (“exhausted”) T cells.
Partners in the international consortium CAR T-REX announce the awarding of a highly competitive EIC Pathfinder Open grant, following the positive evaluation of their project entitled ‘CAR T Cells Rewired to Prevent EXhaustion in the Tumour Microenvironment’.
The prestigious Johann Georg Zimmermann Medal was awarded this year to LIT scientist Prof. Hinrich Abken in recognition of his lifetime achievements.
T cells, working within our immune system, can potentially infiltrate tumors and kill cancer cells. But they often get worn out or ‘exhausted,’ which puts the anti-cancer immune reaction on hold.
Dr. Bittner developed a new type of synthetic biosensor, so-called artificial immune receptors (AIRs), with the help of which Treg cells can be reprogrammed into intelligent ‘smart’ Tregs.
